Abiopharma

🔍 Litinsky James H. (Director)

Company: MP Materials Corp. / DE (MP)

Report Date: 2026-04-17

Detailed Transactions and Holdings:

• Sold 40,821 shares of Common Stock at $64.05 per share (Direct)
  Date: 2026-04-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 12,765,144.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 259,179 shares of Common Stock at $64.03 per share (Direct)
  Date: 2026-04-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 12,505,965.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-17 | Code: H | shares_owned_after: 216,397.00

Footnotes:

• F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2025.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.00 to $64.28. The reporting person undertakes to provide to MP Materials Corp., any security holder of MP Materials Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
• F3: James Litinsky as sole trustee of the James Henry Litinsky, Trustee of James Henry Litinsky Revocable Trust u/a/d 10/19/2011.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.00 to $64.24. The reporting person undertakes to provide to MP Materials Corp., any security holder of MP Materials Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.